Cargando…

KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors

BACKGROUND: Few screening markers for malignant transformation in borderline ovarian tumors (BOT) have been clearly established. The kinase noncatalytic C-lobe domain containing 1 (KNDC1), a brain-specific Ras guanine nucleotide exchange factor, negatively regulates dendrite growth. However, the bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shuqian, Shen, Jiayu, Fei, Jing, Zhu, Xiaoqing, Yin, Meichen, Zhou, Jianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986543/ https://www.ncbi.nlm.nih.gov/pubmed/32158223 http://dx.doi.org/10.2147/OTT.S223304

Ejemplares similares

Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
por: Yin, Meichen, et al.
Publicado: (2019)

Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis
por: Shen, Jiayu, et al.
Publicado: (2019)

Effect of KNDC1 overexpression on the senescence of human umbilical vein endothelial cells
por: Ji, Jinrui, et al.
Publicado: (2018)

Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
por: Shen, Jiayu, et al.
Publicado: (2018)

KNDC1 knockdown protects human umbilical vein endothelial cells from senescence
por: ZHANG, CHUNYAN, et al.
Publicado: (2014)

LINC01088 inhibits tumorigenesis of ovarian epithelial cells by targeting miR-24-1-5p
por: Zhang, Weijiang, et al.
Publicado: (2018)

Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy
por: Okumura, Toshiyuki, et al.
Publicado: (2018)

Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors
por: Ye, Rongping, et al.
Publicado: (2021)

Malignant Transformation of a Borderline Ovarian Tumor With Pulmonary and Pleural Metastases After Years of Latency: A Case Report and Literature Review
por: Ma, Jiang-wei, et al.
Publicado: (2020)

DNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors
por: el Din, Amina A. Gamal, et al.
Publicado: (2015)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Controversies in borderline ovarian tumors
por: Seong, Seok Ju, et al.
Publicado: (2015)

p14 expression differences in ovarian benign, borderline and malignant epithelial tumors
por: Cabral, Vinicius Duarte, et al.
Publicado: (2016)

Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors
por: Zhang, Shuang, et al.
Publicado: (2019)

Genomic aberrations in borderline ovarian tumors
por: Micci, Francesca, et al.
Publicado: (2010)

Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors
por: Xiao, Fuxia, et al.
Publicado: (2022)

Evaluation of selected ultrasonographic parameters and marker levels in the preoperative differentiation of borderline ovarian tumors and ovarian cancers
por: Sobiczewski, Piotr, et al.
Publicado: (2012)

Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass
por: Yu, Xin-Ping, et al.
Publicado: (2020)

The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
por: Shen, Fang, et al.
Publicado: (2017)

Can the ultrasound microcystic pattern accurately predict borderline ovarian tumors?
por: Liu, Danyi, et al.
Publicado: (2023)

Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors
por: Moon, Min Hoan, et al.
Publicado: (2023)

Borderline ovarian tumors: a review of treatment.
por: Chambers, J. T.
Publicado: (1989)

Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors
por: Plett, Helmut, et al.
Publicado: (2020)

Deep learning for the ovarian lesion localization and discrimination between borderline and malignant ovarian tumors based on routine MR imaging
por: Wang, Yida, et al.
Publicado: (2023)

Develop a nomogram to predict overall survival of patients with borderline ovarian tumors
por: Gong, Xiao-Qin, et al.
Publicado: (2022)

MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation
por: Nakai, Go, et al.
Publicado: (2018)

Parameters of Blood Count and Tumor Markers in Patients with Borderline Ovarian Tumors: A Retrospective Analysis and Relation to Staging
por: Nomelini, Rosekeila Simões, et al.
Publicado: (2012)

Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors
por: Yun, Tae Hui, et al.
Publicado: (2022)

Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors
por: Dolivet, Enora, et al.
Publicado: (2023)

Epithelial borderline ovarian tumor: Diagnosis and treatment strategy
por: Ushijima, Kimio, et al.
Publicado: (2015)

Clinicopathological aspects of patients with recurrence of borderline ovarian tumors
por: Oh, Sumin, et al.
Publicado: (2015)

Histopathological Patterns of Microinvasion in Ovarian Serous Borderline Tumors
por: CÎRSTEA, A.E., et al.
Publicado: (2018)

Recurrence characteristics and clinicopathological results of borderline ovarian tumors
por: Niu, Lina, et al.
Publicado: (2021)

The usefulness of intraoperative consultation for the diagnosis of borderline ovarian tumors
por: Salcedo-Hernández, Rosa A., et al.
Publicado: (2021)

A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component
por: Hammouda, Seifeddine Ben, et al.
Publicado: (2022)

A nomogram model based on clinical markers for predicting malignancy of ovarian tumors
por: Gao, Bingsi, et al.
Publicado: (2022)

The Discrepancy between Preoperative Tumor Markers and Imaging Outcomes in Predicting Ovarian Malignancy
por: Shin, Kyung-Hwa, et al.
Publicado: (2022)

Clinical Characteristics Predict Recurrence in Borderline Ovarian Tumor Patients with Fertility-Preserving Surgery
por: He, Yunan, et al.
Publicado: (2022)

Computed tomography-based texture assessment for the differentiation of benign, borderline, and early-stage malignant ovarian neoplasms
por: He, Ziying, et al.
Publicado: (2023)

Differential Expression of Progesterone Receptor Isoforms A and B in the Normal Ovary, and in Benign, Borderline, and Malignant Ovarian Tumors
por: Akahira, Jun‐ichi, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_5ech144c9lu9mjhlnjgtecq1e5